Myzat 200 mg/5ml Powder for oral suspension
PDF Leaflet Revision Date: 22 May 2020
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for mild to moderate infections caused by susceptible organisms.
Dosage (summary)
Adults: 500 mg once daily. Children: 10 mg/kg once daily for 3 days.
Special Populations
- Hepatic impairment
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Use in pregnancy only if clearly needed; caution in lactation due to secretion in breast milk.
Key Drug Interactions
- Ergot derivatives
- Warfarin
- Digoxin
Contraindications
- Hypersensitivity to azithromycin or macrolides
- Severe hepatic impairment
Common side effects
- Diarrhoea
- Nausea
- Dizziness
- Headache
Counselling Points
- Take with food
- Monitor for allergic reactions
- Avoid simultaneous use with antacids
Serious warnings
- QT prolongation
- Hepatotoxicity
- Severe allergic reactions
Important Disclaimer
The Myzat 200 mg/5ml Powder for oral suspension professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
